Please read and agree to the terms and conditions of this site.
@techcrunch.com 2 months ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@abcnews.go.com 7 months ago
Owner of California biolab that fueled bio-weapons rumors charged with mislabeling, lacking permits
@itsmuzza2004 1 year ago
RT @IamAritraG: 🩺Segregation Process of Hospital Bio-Medical Waste #DataScientists #MachineLearning #digitalhealth #eHealth #innovation #technology #web3 #metaverse #python #smartcities #robots #Robotics #AI #GenerativeAI #ChatGPT #NLP #Analytics… https://t.co/7nIbt0sKC3
@IamAritraG 1 year ago
🩺Segregation Process of Hospital Bio-Medical Waste #DataScientists #MachineLearning #digitalhealth #eHealth #innovation #technology #web3 #metaverse #python #smartcities #robots #Robotics #AI #GenerativeAI #ChatGPT #NLP #Analytics #tech #innovation #5G #marketing #digital… https://twitter.com/i/web/status/1645423049481793549 https://t.co/dI1KJFic8e
@techcrunch.com 2 years ago
Kiwi Bio aims to free irritable bowel syndrome sufferers from restrictive diets
@slashgear.com 2 years ago
Biosensors created using biocompatible ink could be useful during surgery
@ipfconline1 3 years ago
[#HealthTech] Bio-inspired algorithm detects early signs of breast cancer https://medicalxpress.com/news/2021-03-bio-inspired-algorithm-early-breast-cancer.html v/ @medical_xpress #HealthTech #AI #MachineLearning #TechForGood Cc @MHiesboeck @andi_staub @ahier @Fabriziobustama @SpirosMargaris @sallyeaves @jblefevre60 https://t.co/HnfWScK0RV
@xconomy.com 3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com 3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com 3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com 3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@marcusborba 3 years ago
Multimodal Depression Severity Prediction from medical bio-markers using #MachineLearning Tools and Technologies. #BigData #Analytics #RStats #Python #JavaScript #ReactJS #Serverless #IoT #Linux #100DaysofCode #Programming #DataScience #DeepLearning #AI https://arxiv.org/abs/2009.05651 https://t.co/sEhdIXpzVv
@xconomy.com 3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com 3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com 4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com 4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com 4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com 4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@engadget.com 4 years ago
Feles wants to build all-in-one bio labs for the intensely curious
@xconomy.com 4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com 4 years ago
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More
@xconomy.com 4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com 4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com 4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com 4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More